Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ISONIAZID
- Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
- 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam
- Subclinical TB With Innovative Modified Short-course Regimens
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
- BTZ-043 Dose Evaluation in Combination and Selection
- Intensified Short Course Regimen for TBM in Adults
- PanACEA - STEP2C -01
- Short-course Regimens for the Treatment of Pulmonary Tuberculosis
- The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis
- Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
- The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study
- Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
- Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)
- A Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Ethionamide Alone and in Combination With BVL-GSK098
- Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
- Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
- Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
- One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
- Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
- The Prophylaxis of Tuberculosis According to TSPOT Results After Kidney Transplantation
- Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
- Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)
- Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
- Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
- Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid
- A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
- Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
- Treatment Success and Safety of 4 Weeks of Daily Rifapentine and Isoniazid (1HP) vs. 12 Weeks of Weekly Rifapentine and Isoniazid (3HP) for Prevention of Tuberculosis in HIV-uninfected Individuals (1v3HP for TPT in HIV-uninfected Individuals)
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
- Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
- Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
- Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
- Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct
- Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
- Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
- Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™
- Economic Evaluation of New MDR TB Regimens
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
- Risk of SDRs Under 3HP and 1HP Regimen for LTBI
- Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
- BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
- Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy
- Azacytidine During Anti-tuberculosis Therapy
- Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)
- A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin
- Doravirine, Rifapentine and Isoniazid Interaction
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)
- Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
- Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy
- Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
- Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
- Tuberculosis Clinical Trials Consortium Study 35
- A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status
- Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
- Pilot Clinical Trial of PRS TB Regimen I - Phase II
- Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms
- Pharmacokinetic Study of Linezolid for TB Meningitis
- Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)
- Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis
- Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
- Phase 2a Study of PBTZ169
- Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection
- Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)
- Treatment of Latent Tuberculosis in Socially Marginalised Citizens
- The Individualized M(X) Drug-resistant TB Treatment Strategy Study
- Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis
- Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis
- Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
- Prevention of Tuberculosis in Prisons
- Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
- Optimizing Treatment to Improve TBM Outcomes in Children
- Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
- The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC)
- Improving the Management of Drug Resistant Tuberculosis in the UK
- Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid
- Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers
- The Correlate of Risk Targeted Intervention Study
- Taima TB: 3HP Study
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
- Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women
- Infant TB Infection Prevention Study
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
- Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
- Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
- Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
- Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
- PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
- Assessing PA-824 for Tuberculosis (the APT Trial)
- Brief Bactericidal Activity of Anti-Tuberculosis Drugs
- Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
- Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan
- Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects
- HRZE Fasted/Fed in Newly Diagnosed TB
- Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide
- Patients Response to Early Switch To Oral:Osteomyelitis Study
- NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis
- A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers
- Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection
- High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)
- ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)
- Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
- Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
- Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
- Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy
- Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
- Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
- "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
- Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
- A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis
- Essentiality of INH in TB Therapy
- Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
- Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
- Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
- Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
- Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs
- Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica
- Trial of High-Dose Rifampin in Patients With TB
- Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
- A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Fol
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment
- Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
- REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
- Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.
- Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)
- Efficacy of Antituberculous Therapy in Management of Sarcoidosis
- QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
- Replacement of Vitamin D in Patients With Active Tuberculosis
- Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
- Isoniazid (INH) Treatment Based on ELISPOT Assay
- The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
- Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis
- Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
- Study of Daily Rifapentine for Pulmonary Tuberculosis
- Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
- Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis
- Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
- NAT2 in Re-challenge of INH in Patients With Hepatitis
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
- A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)
- D-Cycloserine Enhancement of Exposure in Social Phobia
- Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
- Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
- TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
- High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis
- Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
- Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
- Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
- Metronidazole for Pulmonary Tuberculosis (South Korea)
- Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
- Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
- Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis
- Preventive Therapy for Tuberculosis in HIV Infected Persons
- Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children
- Cotrifazid Safety and Efficacy Against Malaria
- A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
- Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia
- Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
- Treatment of Latent Tuberculosis Infection With Isoniazid
- Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
- TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection
- Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment
- A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts
- Tuberculosis Treatment Shortening Trial
- Treatment of Latent TB Infection for Jailed Persons
- TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)
- Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
- Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
- Vitamin A Therapy for Tuberculosis
- Tuberculosis Prevention for HIV Infected Adults
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
- TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz
- TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
- TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
- TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
- TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB
- TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
- Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen
- Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
- Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
- The Treatment of Tuberculosis in HIV-Infected Patients
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
- Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDR
- A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
- Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
- Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
Clinical trials list
click for details